Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCP1202 vs HGP1011 or HCP0910 in COPD
NCT02941679Phase 3Unknown
- Sponsor
- Hanmi Pharmaceutical
- Start
- Oct 2016
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of fluticasone propionate, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by Hanmi Pharmaceutical. Status: unknown.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02941679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941679.